These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7704323)

  • 1. Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.
    Hayashi Y; Ishii N; Obayashi C; Jinnai K; Hanioka K; Imai Y; Itoh H
    Virchows Arch; 1995; 426(1):43-50. PubMed ID: 7704323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
    Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
    Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of p53, EGF, EGF-receptor, v-erb B and ras p21 in squamous cell carcinoma of hypopharynx.
    Otsu M; Hayashi Y; Amatsu M; Itoh H
    Kobe J Med Sci; 1994 Dec; 40(5-6):139-53. PubMed ID: 7616733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical results of transhiatal esophagectomy for carcinoma of the lower thoracic esophagus according to biological markers.
    Hirai T; Kuwahara M; Yoshida K; Kagawa Y; Hihara J; Yamashita Y; Toge T
    Dis Esophagus; 1998 Oct; 11(4):221-5. PubMed ID: 10071802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigen.
    Gilhus NE; Jones M; Turley H; Gatter KC; Nagvekar N; Newsom-Davis J; Willcox N
    J Clin Pathol; 1995 May; 48(5):447-55. PubMed ID: 7629292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method.
    Nonomura A; Ohta G; Nakanuma Y; Izumi R; Mizukami Y; Matsubara F; Hayashi M; Watanabe K; Takayanagi N
    Liver; 1988 Jun; 8(3):157-66. PubMed ID: 2839749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of oestrogen receptor, progesterone receptor, trefoil factor 1, and epidermal growth factor and its receptor in pancreatic cystic neoplasms and pancreatic ductal adenocarcinoma.
    Yeh TS; Jan YY; Chiu CT; Ho YB; Chen TC; Lee KF; Chan KM; Hsu JC; Hwang TL; Chen MF
    Gut; 2002 Nov; 51(5):712-6. PubMed ID: 12377812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
    Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes.
    Game SM; Huelsen A; Patel V; Donnelly M; Yeudall WA; Stone A; Fusenig NE; Prime SS
    Int J Cancer; 1992 Sep; 52(3):461-70. PubMed ID: 1328069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
    Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U
    Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
    Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
    Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of EGF, EGFR and PCNA in laryngeal lesions.
    Wen QH; Nishimura T; Miwa T; Nagayama I; Furukawa M
    J Laryngol Otol; 1995 Jul; 109(7):630-6. PubMed ID: 7561470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
    Niikura H; Sasano H; Kaga K; Sato S; Yajima A
    Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.
    Archer SG; Eliopoulos A; Spandidos D; Barnes D; Ellis IO; Blamey RW; Nicholson RI; Robertson JF
    Br J Cancer; 1995 Nov; 72(5):1259-66. PubMed ID: 7577479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of ras p21 and epidermal growth factor receptor during various stages of tumour progression in oral mucosa.
    Kannan S; Balaram P; Chandran GJ; Pillai MR; Mathew B; Nair MK
    Tumour Biol; 1994; 15(2):73-81. PubMed ID: 8184255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunohistochemical study on epidermal growth factor and its receptor in human pancreatic carcinoma].
    Yamanaka Y; Onda M; Uchida E; Kobayashi T; Sasajima K; Tokunaga A; Tajiri T; Egami K; Asano G
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jul; 87(7):1544-50. PubMed ID: 2214281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
    Lipponen P; Eskelinen M
    Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.